- Home
- AEVA vs HROW Comparison
AEVA vs HROW Comparison
Compare AEVA & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEVA
- HROW
- Stock Information
- Founded
- AEVA 2019
- HROW 1998
- Country
- AEVA United States
- HROW United States
- Employees
- AEVA N/A
- HROW N/A
- Industry
- AEVA Auto Parts:O.E.M.
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- AEVA Consumer Discretionary
- HROW Health Care
- Exchange
- AEVA Nasdaq
- HROW Nasdaq
- Market Cap
- AEVA 1.0B
- HROW 1.1B
- IPO Year
- AEVA N/A
- HROW N/A
- Fundamental
- Price
- AEVA $25.13
- HROW $30.66
- Analyst Decision
- AEVA Buy
- HROW Strong Buy
- Analyst Count
- AEVA 6
- HROW 6
- Target Price
- AEVA $16.20
- HROW $59.00
- AVG Volume (30 Days)
- AEVA 2.1M
- HROW 440.3K
- Earning Date
- AEVA 08-06-2025
- HROW 08-06-2025
- Dividend Yield
- AEVA N/A
- HROW N/A
- EPS Growth
- AEVA N/A
- HROW N/A
- EPS
- AEVA N/A
- HROW N/A
- Revenue
- AEVA $10,326,000.00
- HROW $212,858,000.00
- Revenue This Year
- AEVA $94.59
- HROW $44.92
- Revenue Next Year
- AEVA $165.22
- HROW $38.12
- P/E Ratio
- AEVA N/A
- HROW N/A
- Revenue Growth
- AEVA 95.90
- HROW 53.49
- 52 Week Low
- AEVA $2.20
- HROW $19.31
- 52 Week High
- AEVA $28.10
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- AEVA 68.28
- HROW 57.58
- Support Level
- AEVA $21.90
- HROW $30.01
- Resistance Level
- AEVA $28.10
- HROW $31.63
- Average True Range (ATR)
- AEVA 2.07
- HROW 1.59
- MACD
- AEVA 0.25
- HROW 0.02
- Stochastic Oscillator
- AEVA 74.17
- HROW 66.10
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.